![](/img/cover-not-exists.png)
The proteasome inhibitor carfilzomib (Cfz) induces cardiotoxicity in vivo: molecular mechanisms and the cardioprotective effect of metformin (Met)
Kremastiotis, G., Efentakis, P., Varela, A., Davos, C.H., Tsoumani, M., Papanagnou, E.D., Trougakos, I.P., Kastritis, E., Kanaki, Z., Iliodromitis, E.K., Klinakis, A., Dimopoulos, M.A., Terpos, E., AnVolume:
120
Language:
english
Journal:
Journal of Molecular and Cellular Cardiology
DOI:
10.1016/j.yjmcc.2018.05.102
Date:
July, 2018
File:
PDF, 45 KB
english, 2018